SCHEMBL2284758

SCHEMBL2284758

CCC[S+](CC[C@H](N)C(=O)O)C[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O

nearest known ligand 0.79

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CARM1 Q86X55 6/20 0.79
AMD1 P17707 2/20 0.79
PRMT1 Q99873 4/20 0.69
PCMT1 P22061 3/20 0.69
PRMT5 O14744 3/20 0.69
NSD3 Q9BZ95 2/20 0.69
PRMT3 O60678 2/20 0.69
PNMT P11086 2/20 0.69
PRMT6 Q96LA8 2/20 0.69
WDR77 Q9BQA1 2/20 0.69
PRMT7 Q9NVM4 2/20 0.69
ADORA3 P0DMS8 1/20 0.69
KDR P35968 1/20 0.69
PRMT8 Q9NR22 1/20 0.69
NNMT P40261 3/20 0.69
SETD2 Q9BYW2 3/20 0.68
SMYD3 Q9H7B4 1/20 0.68
DOT1L Q8TEK3 5/20 0.68
NSD2 O96028 4/20 0.68
SETD7 Q8WTS6 4/20 0.68

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2284764 1.00 CARM1 (0.79) CARM1AMD1PRMT1PCMT1PRMT5
SCHEMBL2284776 1.00 CARM1 (0.79) CARM1AMD1PRMT1PCMT1PRMT5
SCHEMBL2287080 0.94 CARM1 (0.81) CARM1AMD1PRMT1PCMT1PRMT5
SCHEMBL2287096 0.94 CARM1 (0.81) CARM1AMD1PRMT1PCMT1PRMT5
SCHEMBL2287090 0.94 CARM1 (0.81) CARM1AMD1PRMT1PCMT1PRMT5
SCHEMBL30930805 0.90 CARM1 (0.78) CARM1AMD1PRMT1PCMT1PRMT5
SCHEMBL30965845 0.90 CARM1 (0.78) CARM1AMD1PRMT1PCMT1PRMT5
SCHEMBL2284468 0.89 CARM1 (0.73) CARM1AMD1PRMT1PCMT1PRMT5
SCHEMBL2284459 0.89 CARM1 (0.73) CARM1AMD1PRMT1PCMT1PRMT5
SCHEMBL2284452 0.89 CARM1 (0.73) CARM1AMD1PRMT1PCMT1PRMT5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8008007-B2 S-adenosyl-L-methionine analogs with extended activated groups for transfer by methyltransferases RWTH AACHEN (DE) 2011-08-30 US disclosed
EP-1874790-B1 NEW S-ADENOSYL-L-METHIONINE ANALOGS WITH EXTENDED ACTIVATED GROUPS FOR TRANSFER BY METHYLTRANSFERASES RWTH AACHEN (DE) 2010-08-18 EP disclosed
US-20090018101-A1 S-ADENOSYL-L-METHIONINE ANALOGS WITH EXTENDED ACTIVATED GROUPS FOR TRANSFER BY METHYLTRANSFERASES RWTH AACHEN (DE) 2009-01-15 US disclosed
EP-1874790-A2 NEW S-ADENOSYL-L-METHIONINE ANALOGS WITH EXTENDED ACTIVATED GROUPS FOR TRANSFER BY METHYLTRANSFERASES RWTH Aachen (DE) 2008-01-09 EP disclosed
WO-2006108678-A2 NEW S-ADENOSYL-L-METHIONINE ANALOGS WITH EXTENDED ACTIVATED GROUPS FOR TRANSFER BY METHYLTRANSFERASES RWTH AACHEN (DE) 2006-10-19 WO disclosed
EP-1712557-A1 New s-adenosyl-L-methionine analogues with extended activated groups for transfer by methyltransferases RWTH Aachen (DE) 2006-10-18 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090018101-A1 S-ADENOSYL-L-METHIONINE ANALOGS WITH EXTENDED ACTIVATED GROUPS FOR TRANSFER BY METHYLTRANSFERASES BHMT2, MSRB3, PRMT3 CARM1 35/4885AMD1 20/4885PRMT1 10/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.